Interim report of Atria Plc 1 January - 30 September 2015

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Interim report of Atria Plc 1 January - 30 September 2015

Seinäjoki, Finland, 2015-10-29 07:00 CET (GLOBE NEWSWIRE) -- Atria Plc, Interim Report, 29 October 2015 at 8.00 am INTERIM REPORT OF ATRIA PLC 1 JANUARY–30 SEPTEMBER 2015 Atria Group’s comparable EBIT at the previous year’s level July–September 2015 – Consolidated net sales fell by 7.5% to EUR 337.1 million (EUR 364.4 million). At comparable exchange rates, the decline was 4.6%. – Consolidated EBIT was EUR 15.1 million (EUR 16.2 million), or 4.5% (4.4%) of net sales. EBIT for the comparative period includes EUR 0.6 million of non-recurring income. – The investment in the pig cutting plant in Nurmo is progressing according to plan. – Atria Finland to improve the Sahalahti poultry unit’s productivity. – Atria to increase efficiency in sales, marketing and logistics in Sweden – Net liabilities declined, and net gearing was 55.8% (31 December 2014: 61.8%). January–September 2015 – Consolidated net sales fell by 6.9% to EUR 989.2 million (EUR 1,062.7 million). At comparable exchange rates, the decline was 4.3%. – Consolidated EBIT was EUR 24.2 million (EUR 22.0 million), or 2.4% (2.1%) of net sales. BIT includes a total of EUR +1.9 million (EUR -0.6 million) of non-recurring items. – Atria initiated an investment of EUR 36 million in the modernisation of the pig cutting plant in Nurmo. – The sale of the Falbygdens cheese business to Arla in Sweden was completed in April. – Atria acquired the operations of Aalbaek Specialiteter, a manufacturer of organic cold cuts, in Denmark in May. – The Campofarm piggery real estate in Russia was sold in June.  

  Q3 Q3 Q1–Q3 Q1–Q3  
EUR million 2015 2014 2015 2014 2014
Group    Net sales 337.1 364.4 989.2 1,062.7 1,426.1
   EBIT 15.1 16.2 24.2 22.0 40.6
   EBIT, % 4.5% 4.4% 2.4% 2.1% 2.8%
   Profit before taxes 13.0 13.6 17.3 17.7 34.0
   Earnings per share, EUR 0.27 0.35 0.38 0.45 0.93
   Non-recurring items* -       0.6 1.9 -0.6 1.0
  Net sales by segment          
    Atria Finland 235.1 238.5 681.0 701.9 945.5
    Atria Scandinavia 81.3 93.3 246.7 277.0 371.9
    Atria Russia 19.1 29.2 56.5 76.5 98.8
    Atria Baltic 8.4 9.0 24.9 26.0 34.5
  EBIT by segment          
    Atria Finland 9.5 11.8 16.1 18.0 33.6
    Atria Scandinavia 5.2 5.9 9.6 10.2 14.9
    Atria Russia 0.5 -1.5 0.2 -4.8 -5.7
    Atria Baltic 0.0 0.1 0.1 -0.2 -0.0
*Non-recurring items are included in the reported figures          
           

July–September 2015 Atria Group’s net sales for July–September totalled EUR 337.1 million (EUR 364.4 million). Net sales fell by EUR 27.3 million year-on-year. This decrease was partly due to the sale of the Falbygdens cheese business and the weakening of the rouble. Additionally, net sales were brought down by lower-than-usual sales during the barbecue season and intense competition. EBIT amounted to EUR 15.1 million (EUR 16.2 million). Comparable EBIT was roughly the same as in the corresponding period last year, EUR 15.1 million (EUR 15.6 million). At the beginning of September, Atria Finland launched a project to improve the productivity of chicken production at the Sahalahti plant. The project will identify overlaps in Atria’s current operations and the areas in need of improvement at the plant. Atria estimates that removing overlapping functions and improving efficiency will result in annual savings of about EUR 1.5 million, which will be realised as of the second quarter of 2016. In September, Atria Scandinavia initiated the reorganisation of its operations in Sweden. The reorganisation will affect sales, marketing and logistics. Atria estimates that the reorganisation and improved efficiency will result in annual savings of about EUR 1.8 million, most of which will be realized as of the beginning of 2016. Atria Finland’s net sales for July–September totalled EUR 235.1 million (EUR 238.5 million), down by EUR 3.4 million year-on-year. EBIT amounted to EUR 9.5 million (EUR 11.8 million). EBIT for the comparative period includes EUR 0.6 million of non-recurring income. The decrease in net sales and profitability was due to weaker consumer demand and tougher competition, which resulted in lower sales prices. The sales of barbecue products were down from the year before. Atria Finland’s cost-efficiency has remained at a good level. Atria Scandinavia’s net sales for July–September totalled EUR 81.3 million (EUR 93.3 million) and EBIT was EUR 5.2 million (EUR 5.9 million). The decrease in net sales and EBIT was due to the sale of the Falbygdens cheese business. The consolidation of Aalbaek Specialiteter’s operations into Atria has progressed well. Atria Russia’s net sales for July–September totalled EUR 19.1 million (EUR 29.2 million). Net sales in euros fell mainly due to the weakening of the rouble. Net sales in the local currency decreased by 4.2% year-on-year, mainly because consumers shifted to lower-priced products. EBIT was EUR 0.5 million (EUR -1.5 million). EBIT improved due to price increases, the elimination of unprofitable products, a successful summer season for the Sibylla business, and improved cost-efficiency in general. Atria Baltic’s net sales for July–September amounted to EUR 8.4 million (EUR 9.0 million). EBIT was EUR 0.0 million (EUR 0.1 million). The sales of barbecue products were lower than in the corresponding period last year due to the cold and rainy weather. Authorities have imposed regional export and sales bans in order to prevent the spread of African swine fever, which has reduced profitability and made it more difficult to use local meat. January–September 2015 Atria Group’s net sales for January–September totalled EUR 989.2 million (EUR 1,062.7 million). Net sales fell by EUR 73.5 million year-on-year. This decrease was due to the sale of the Falbygdens cheese business and the weakening of the rouble over the comparative period. Additionally, net sales were brought down by lower-than-usual sales of barbecue products and intense competition. EBIT amounted to EUR 24.2 million (EUR 22.0 million), which includes a total of EUR +1.9 million (EUR -0.6 million) of non-recurring items. Comparable EBIT was EUR 22.3 million (EUR 22.6 million). At the beginning of the year, Atria Finland launched an investment worth around EUR 36 million in expanding and modernising its pig cutting plant in Nurmo, Finland. New production facilities will be built next to the old plant, and the existing facilities will be renovated and automated using the latest production technology. The investment will substantially raise the pig cutting plant’s productivity and profitability: it is expected to generate annual cost savings of around EUR 8 million in the plant’s operations. The Swedish Competition Authority approved the sale of Atria Scandinavia’s Falbygdens cheese business to Arla on 11 March 2015. The selling price was EUR 29.3 million when the change in net working capital as per the sales agreement was taken into account. The operations were transferred to Arla Foods AB on 1 April 2015.  The sale will reduce Atria’s annual net sales by EUR 52 million and EBIT by EUR 3 million. In May, Atria acquired the operations of Aalbaek Specialiteter A/S, a Danish manufacturer of organic cold cuts, for EUR 5.5 million. Aalbaek’s annual net sales amount to around EUR 10 million. Aalbaek is the top organic cold cuts brand in Denmark. The transaction will strengthen Atria’s market-leading position in cold cuts in the country. Aalbaek’s brands and business, including all agreements, were transferred to Atria as part of the deal, along with a charcuterie and production facilities in Farre. The operations were consolidated into Atria from 11 May 2015. Atria sold a Russian subsidiary on 24 June 2015 for EUR 4.5 million. The company owned a farm property near Moscow. Costs of EUR 0.6 million were recorded for the sale as non-recurring items. Additionally, translation differences accrued in equity improved earnings by EUR 2.5 million.

Investments during the period under review totalled EUR 39.0 million (EUR 55.3 million). The Group’s free cash flow for the period (operating cash flow - cash flow from investments) was EUR 38.2 million (EUR -5.4 million) and net liabilities were EUR 224.3 million (31 December 2014: EUR 250.7 million). Atria Finland’s net sales for January–September totalled EUR 681.0 million (EUR 701.9 million), down by EUR 20.9 million year-on-year. This decline was due to weaker consumer demand and tougher price competition. The sales of barbecue products were down from the year before. EBIT amounted to EUR 16.1 million (EUR 18.0 million). EBIT for the comparative period included EUR -0.2 million of non-recurring items. EBIT was brought down by a decrease in sales prices, which was due to the oversupply of meat in the international market and intense price competition. Atria Finland’s cost-efficiency has remained at a good level. Atria Scandinavia’s net sales for January–September totalled EUR 246.7 million (EUR 277.0 million). This decrease was due to the sale of the Falbygdens cheese business, completed on 1 April 2015. EBIT for January–September was EUR 9.6 million (EUR 10.2 million). The consolidation of Aalbaek Specialiteter’s operations into Atria has progressed well. Atria Russia’s net sales for January–September totalled EUR 56.5 million (EUR 76.5 million). Net sales in euros fell due to the weakening of the rouble. Net sales in the local currency grew by 2.3% year-on-year. EBIT was EUR 0.2 million (EUR -4.8 million), which includes a total of EUR +1.9 million of non-recurring items. Comparable EBIT came to EUR -1.7 million (EUR -4.8 million). The positive performance was due to increases in sales prices and better cost-efficiency. Atria has implemented all the planned structural reforms, which have had a positive impact on the EBIT. Meanwhile, EBIT was brought down by an increase in raw material prices and lower consumer demand. Atria Baltic’s net sales for January–September totalled EUR 24.9 million (EUR 26.0 million). EBIT for January–September was EUR 0.1 million (EUR -0.2 million). EBIT for the comparative period includes EUR 0.4 million of non-recurring costs. Prolonged oversupply in the international meat market and fierce price competition in the retail market have brought down meat prices. The sales of barbecue products were lower than in the corresponding period last year due to the cold and rainy weather. In late summer, authorities imposed regional export and sales bans in order to prevent the spread of African swine fever, which reduces profitability and makes it more difficult to use local meat.  

Key indicators        
EUR million 30.9.15 30.9.14   31.12.14
         
Equity/share, EUR 14.07 14.38   14.22
Interest-bearing liabilities 225.5 314.9   254.1
Equity ratio, % 46.0 42.1   44.0
Gearing, % 56.1 76.8   62.6
Net gearing, % 55.8 75.9   61.8
Gross investments in fixed assets 39.0 55.3   62.7
Gross investments, % of net sales 3.9 5.2   4.4
Average FTE 4,304 4,773   4,715

Outlook for the future In 2014, consolidated EBIT without non-recurring items was EUR 39.6 million. In 2015, EBIT is projected to be roughly the same and net sales are expected to decrease. Publication procedure Atria Plc complies with the publication procedure in accordance with standard 5.2b of the Financial Supervisory Authority and publishes its 1 JANUARY – 30 SEPTEMBER 2015 interim report release as an attachment to this company announcement. The full interim report is available on the company’s website at www.atriagroup.com. For more information, please contact Juha Gröhn, CEO, Atria Plc, tel. +358 400 684 224. Invitation to a press conference A press conference conducted in Finnish will be arranged today 29 October 2015 at 9:30 am at Atria offices in Helsinki, address Läkkisepäntie 23, Helsinki. The presentation material will be available on the company’s website (www.atriagroup.com/en/investors/FinancialInformation/quarterlyreports) after the distribution of the interim report and as an attachment to this company announcement. ATRIA PLC Board of Directors DISTRIBUTION Nasdaq OMX Helsinki Ltd Major media www.atriagroup.com  

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 121

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading
Employer Ghosting Is a Quiet Talent-Cost Problem Today

Updated Category News Views 173

Silence is cheap right up until a company needs talent again. Then the unanswered email, abandoned interview loop, or vanished promise of next steps comes back with a price tag—maybe not neatly labeled in a quarterly filing, but real all the same. LiveCareer’s April 14, 2026 survey of 1,008 employed U.S. adults lands on an uncomfortable point: candidates remember...

Continue Reading
WaterField’s Nova Case Bets on Better Handheld Carry

Updated Category News Views 211

Tiny handhelds have spawned a surprisingly fussy luggage problem: protection without the clown-show aesthetic. WaterField Designs is taking a clean swing at that with a custom case for the Retroid Pocket Nova, a sleeve-like carrier built around the device rather than some generic pouch that leaves everything rattling around inside. This is not a market-moving corporate...

Continue Reading
ModuleMD Takes Allergy EHR AI Beyond the Usual Hype Cycle

Updated Category News Views 210

Allergy Workflows Are Where This Has to Earn Its Keep Allergy clinics do not need another shiny dashboard clogging up a workstation. They need less typing, fewer handoffs, cleaner documentation, and fewer administrative chores slipping through the cracks while a packed day keeps moving. That is the practical lens for ModuleMD's ACAAI 2026 presentation in Phoenix: not...

Continue Reading
CCAPP Holiday Training Targets Seasonal Recovery Strain

Updated Category News Views 126

December cheer has a nasty habit of hiding the people barely holding themselves together. CCAPP’s upcoming virtual workshop, Hope for the Holidays: Understanding Depression, Stress & Resilience During the Holiday Season, takes that uncomfortable reality seriously rather than treating it like a seasonal footnote. For behavioral health workers supporting people in...

Continue Reading
Kyverna Probe Reopens IPO Disclosure Questions for Investors

Updated Category News Views 123

Clinical-trial caveats have a nasty habit of becoming shareholder headaches years later. Kyverna Therapeutics is back in that uncomfortable zone after Kahn Swick & Foti said it has opened an investigation into whether the company’s officers and directors breached fiduciary duties or otherwise violated state or federal law. For holders of KYTX, this is not a verdict and...

Continue Reading
D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 175

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading
Human Frontier Mission Puts AI Research on Display

Updated Category News Views 95

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 157

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading
QuidelOrtho Faces Fresh Scrutiny Over Savanna Claims

Updated Category News Views 203

A diagnostic launch can turn into a corporate migraine with frightening speed, and QuidelOrtho is staring at exactly that sort of mess. Kahn Swick & Foti said on November 20, 2026, that it has begun investigating whether QuidelOrtho officers or directors breached fiduciary duties or otherwise violated state or federal law. This is not a finding of wrongdoing. It is an...

Continue Reading

Top 5 Most Recently Viewed Articles

dbt Labs Transforms Data Management with MetricFlow Open Source

Updated Category News Views 735

Embracing Open Source with MetricFlow In a groundbreaking move, dbt Labs recently announced its commitment to advancing trustworthy AI by open sourcing MetricFlow. This initiative represents a significant turning point in how organizations manage and utilize data in the era of artificial intelligence. The shift to an Apache 2.0 license not only safeguards the integrity of...

Continue Reading
EssilorLuxottica Achieves Euro 2 Billion Bond Issuance Success

Updated Category News Views 117

EssilorLuxottica's Successful Bond Issuance EssilorLuxottica has reached a noteworthy milestone by successfully issuing a Euro 2 billion bond at an attractive average rate of 2.99%. This strategic financial move highlights the company's strong position in the market and its appeal to investors. Details of the Bond Issuance The bond issuance features tenors of 4.5 years...

Continue Reading
Streamlined Home Selling Solutions Introduced in North Carolina

Updated Category News Views 292

Revolutionizing Home Selling in North Carolina Fair Cash Offers For Homes has recently launched its innovative service, ‘Sell Your House Fast North Carolina,’ designed to facilitate quick and efficient sales for homeowners. With the ever-changing real estate landscape, many individuals find themselves needing to sell their properties under various circumstances,...

Continue Reading
Ipsen Employee Admits to Insider Trading on Cancer Drug Deal

Updated Category News Views 268

Guilty Plea Tied to a Drugmaker’s Takeover Plans An employee at the French pharmaceutical company Ipsen has agreed to plead guilty to insider trading. The case, centered on trading ahead of a proposed acquisition, underscores the stakes around confidentiality in drug development and the pressures that test corporate governance. What Prosecutors Allege Dishant Gupta,...

Continue Reading
Oscar Health Achieves 52-Week Record with $23.45 Stock Price

Updated Category News Views 221

Oscar Health Achieves New Stock Performance Highs In a striking example of market resilience, Oscar Health, Inc. (OSCR) has reached an impressive 52-week high with its stock hitting $23.45. This achievement signifies a remarkable growth phase for the company, which has experienced an incredible one-year change of 288.51%. Investors have shown strong support for Oscar...

Continue Reading